 | • レポートコード：MRC23Q36632 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（2-3日） • 産業分類：医療機器 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界の自動ペプチド連続合成装置市場について調査・分析し、世界の自動ペプチド連続合成装置市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（全自動型、半自動型、手動型）、用途別セグメント分析（研究所、大学、研究センター）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Gyros Protein Technologies AB、Büchi AG、Biotage、CEM、CSBio、AAPPTec、Activotec、MultiSynTech、NJ Biopharmaceuticals LLC、Peptide Machines, Inc.、Protein Technologies, Inc.、Intavis AGなどが含まれています。世界の自動ペプチド連続合成装置市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、自動ペプチド連続合成装置市場規模を推定する際に考慮しました。本レポートは、自動ペプチド連続合成装置の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、自動ペプチド連続合成装置に関するビジネス上の意思決定に役立てることを目的としています。 ・自動ペプチド連続合成装置市場の概要 - 製品の定義 - 自動ペプチド連続合成装置のタイプ別セグメント - 世界の自動ペプチド連続合成装置市場規模：タイプ別分析（全自動型、半自動型、手動型） - 自動ペプチド連続合成装置の用途別セグメント - 世界の自動ペプチド連続合成装置市場規模：用途別分析（研究所、大学、研究センター） - 世界の自動ペプチド連続合成装置市場規模予測（2018年-2029年） - 自動ペプチド連続合成装置の平均価格推移（2018年-2029年） - 前提条件と制限事項 ・メーカー別競争状況 - メーカー別市場シェア - 世界の主要メーカー、業界ランキング分析 - メーカー別平均価格 - 自動ペプチド連続合成装置市場の競争状況およびトレンド ・自動ペプチド連続合成装置の地域別市場規模 - 北米の自動ペプチド連続合成装置市場規模（2018年-2029年） - アメリカの自動ペプチド連続合成装置市場規模（2018年-2029年） - ヨーロッパの自動ペプチド連続合成装置市場規模（2018年-2029年） - アジア太平洋の自動ペプチド連続合成装置市場規模（2018年-2029年） - 中国の自動ペプチド連続合成装置市場規模（2018年-2029年） - 日本の自動ペプチド連続合成装置市場規模（2018年-2029年） - 韓国の自動ペプチド連続合成装置市場規模（2018年-2029年） - インドの自動ペプチド連続合成装置市場規模（2018年-2029年） - オーストラリアの自動ペプチド連続合成装置市場規模（2018年-2029年） - 中南米の自動ペプチド連続合成装置市場規模（2018年-2029年） - 中東・アフリカの自動ペプチド連続合成装置市場規模（2018年-2029年） ・タイプ別セグメント：全自動型、半自動型、手動型 - 世界の自動ペプチド連続合成装置のタイプ別販売量（2018年-2023年） - 世界の自動ペプチド連続合成装置のタイプ別売上（2018年-2023年） - 世界の自動ペプチド連続合成装置のタイプ別価格 ・用途別セグメント：研究所、大学、研究センター - 世界の自動ペプチド連続合成装置の用途別販売量（2018年-2023年） - 世界の自動ペプチド連続合成装置の用途別売上（2018年-2023年） - 世界の自動ペプチド連続合成装置の用途別価格 ・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向 Gyros Protein Technologies AB、Büchi AG、Biotage、CEM、CSBio、AAPPTec、Activotec、MultiSynTech、NJ Biopharmaceuticals LLC、Peptide Machines, Inc.、Protein Technologies, Inc.、Intavis AG ・産業チェーンと販売チャネルの分析 - 自動ペプチド連続合成装置産業チェーン分析 - 自動ペプチド連続合成装置の主要原材料 - 自動ペプチド連続合成装置の販売チャネル - 自動ペプチド連続合成装置のディストリビューター - 自動ペプチド連続合成装置の主要顧客 ・自動ペプチド連続合成装置市場ダイナミクス - 自動ペプチド連続合成装置の業界動向 - 自動ペプチド連続合成装置市場の成長ドライバ、課題、阻害要因 ・調査成果および結論 ・調査方法とデータソース |
Highlights
The global Automatic Peptide Continuous Synthesizer market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Automatic Peptide Continuous Synthesizer is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Automatic Peptide Continuous Synthesizer is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Automatic Peptide Continuous Synthesizer include Gyros Protein Technologies AB, Büchi AG, Biotage, CEM, CSBio, AAPPTec, Activotec, MultiSynTech and NJ Biopharmaceuticals LLC, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Automatic Peptide Continuous Synthesizer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Automatic Peptide Continuous Synthesizer.
The Automatic Peptide Continuous Synthesizer market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Automatic Peptide Continuous Synthesizer market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Automatic Peptide Continuous Synthesizer manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Gyros Protein Technologies AB
Büchi AG
Biotage
CEM
CSBio
AAPPTec
Activotec
MultiSynTech
NJ Biopharmaceuticals LLC
Peptide Machines, Inc.
Protein Technologies, Inc.
Intavis AG
Segment by Type
Fully Automatic
Aemi-automatic
Manual
Segment by Application
Laboratory
University
Research Center
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Automatic Peptide Continuous Synthesizer manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Automatic Peptide Continuous Synthesizer in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Automatic Peptide Continuous Synthesizer Market Overview
1.1 Product Overview and Scope of Automatic Peptide Continuous Synthesizer
1.2 Automatic Peptide Continuous Synthesizer Segment by Type
1.2.1 Global Automatic Peptide Continuous Synthesizer Market Value Comparison by Type (2023-2029)
1.2.2 Fully Automatic
1.2.3 Aemi-automatic
1.2.4 Manual
1.3 Automatic Peptide Continuous Synthesizer Segment by Application
1.3.1 Global Automatic Peptide Continuous Synthesizer Market Value by Application: (2023-2029)
1.3.2 Laboratory
1.3.3 University
1.3.4 Research Center
1.4 Global Automatic Peptide Continuous Synthesizer Market Size Estimates and Forecasts
1.4.1 Global Automatic Peptide Continuous Synthesizer Revenue 2018-2029
1.4.2 Global Automatic Peptide Continuous Synthesizer Sales 2018-2029
1.4.3 Global Automatic Peptide Continuous Synthesizer Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Automatic Peptide Continuous Synthesizer Market Competition by Manufacturers
2.1 Global Automatic Peptide Continuous Synthesizer Sales Market Share by Manufacturers (2018-2023)
2.2 Global Automatic Peptide Continuous Synthesizer Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Automatic Peptide Continuous Synthesizer Average Price by Manufacturers (2018-2023)
2.4 Global Automatic Peptide Continuous Synthesizer Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Automatic Peptide Continuous Synthesizer, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Automatic Peptide Continuous Synthesizer, Product Type & Application
2.7 Automatic Peptide Continuous Synthesizer Market Competitive Situation and Trends
2.7.1 Automatic Peptide Continuous Synthesizer Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Automatic Peptide Continuous Synthesizer Players Market Share by Revenue
2.7.3 Global Automatic Peptide Continuous Synthesizer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Automatic Peptide Continuous Synthesizer Retrospective Market Scenario by Region
3.1 Global Automatic Peptide Continuous Synthesizer Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Automatic Peptide Continuous Synthesizer Global Automatic Peptide Continuous Synthesizer Sales by Region: 2018-2029
3.2.1 Global Automatic Peptide Continuous Synthesizer Sales by Region: 2018-2023
3.2.2 Global Automatic Peptide Continuous Synthesizer Sales by Region: 2024-2029
3.3 Global Automatic Peptide Continuous Synthesizer Global Automatic Peptide Continuous Synthesizer Revenue by Region: 2018-2029
3.3.1 Global Automatic Peptide Continuous Synthesizer Revenue by Region: 2018-2023
3.3.2 Global Automatic Peptide Continuous Synthesizer Revenue by Region: 2024-2029
3.4 North America Automatic Peptide Continuous Synthesizer Market Facts & Figures by Country
3.4.1 North America Automatic Peptide Continuous Synthesizer Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Automatic Peptide Continuous Synthesizer Sales by Country (2018-2029)
3.4.3 North America Automatic Peptide Continuous Synthesizer Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Automatic Peptide Continuous Synthesizer Market Facts & Figures by Country
3.5.1 Europe Automatic Peptide Continuous Synthesizer Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Automatic Peptide Continuous Synthesizer Sales by Country (2018-2029)
3.5.3 Europe Automatic Peptide Continuous Synthesizer Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Automatic Peptide Continuous Synthesizer Market Facts & Figures by Country
3.6.1 Asia Pacific Automatic Peptide Continuous Synthesizer Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Automatic Peptide Continuous Synthesizer Sales by Country (2018-2029)
3.6.3 Asia Pacific Automatic Peptide Continuous Synthesizer Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Automatic Peptide Continuous Synthesizer Market Facts & Figures by Country
3.7.1 Latin America Automatic Peptide Continuous Synthesizer Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Automatic Peptide Continuous Synthesizer Sales by Country (2018-2029)
3.7.3 Latin America Automatic Peptide Continuous Synthesizer Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Automatic Peptide Continuous Synthesizer Market Facts & Figures by Country
3.8.1 Middle East and Africa Automatic Peptide Continuous Synthesizer Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Automatic Peptide Continuous Synthesizer Sales by Country (2018-2029)
3.8.3 Middle East and Africa Automatic Peptide Continuous Synthesizer Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Automatic Peptide Continuous Synthesizer Sales by Type (2018-2029)
4.1.1 Global Automatic Peptide Continuous Synthesizer Sales by Type (2018-2023)
4.1.2 Global Automatic Peptide Continuous Synthesizer Sales by Type (2024-2029)
4.1.3 Global Automatic Peptide Continuous Synthesizer Sales Market Share by Type (2018-2029)
4.2 Global Automatic Peptide Continuous Synthesizer Revenue by Type (2018-2029)
4.2.1 Global Automatic Peptide Continuous Synthesizer Revenue by Type (2018-2023)
4.2.2 Global Automatic Peptide Continuous Synthesizer Revenue by Type (2024-2029)
4.2.3 Global Automatic Peptide Continuous Synthesizer Revenue Market Share by Type (2018-2029)
4.3 Global Automatic Peptide Continuous Synthesizer Price by Type (2018-2029)
5 Segment by Application
5.1 Global Automatic Peptide Continuous Synthesizer Sales by Application (2018-2029)
5.1.1 Global Automatic Peptide Continuous Synthesizer Sales by Application (2018-2023)
5.1.2 Global Automatic Peptide Continuous Synthesizer Sales by Application (2024-2029)
5.1.3 Global Automatic Peptide Continuous Synthesizer Sales Market Share by Application (2018-2029)
5.2 Global Automatic Peptide Continuous Synthesizer Revenue by Application (2018-2029)
5.2.1 Global Automatic Peptide Continuous Synthesizer Revenue by Application (2018-2023)
5.2.2 Global Automatic Peptide Continuous Synthesizer Revenue by Application (2024-2029)
5.2.3 Global Automatic Peptide Continuous Synthesizer Revenue Market Share by Application (2018-2029)
5.3 Global Automatic Peptide Continuous Synthesizer Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Gyros Protein Technologies AB
6.1.1 Gyros Protein Technologies AB Corporation Information
6.1.2 Gyros Protein Technologies AB Description and Business Overview
6.1.3 Gyros Protein Technologies AB Automatic Peptide Continuous Synthesizer Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Gyros Protein Technologies AB Automatic Peptide Continuous Synthesizer Product Portfolio
6.1.5 Gyros Protein Technologies AB Recent Developments/Updates
6.2 Büchi AG
6.2.1 Büchi AG Corporation Information
6.2.2 Büchi AG Description and Business Overview
6.2.3 Büchi AG Automatic Peptide Continuous Synthesizer Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Büchi AG Automatic Peptide Continuous Synthesizer Product Portfolio
6.2.5 Büchi AG Recent Developments/Updates
6.3 Biotage
6.3.1 Biotage Corporation Information
6.3.2 Biotage Description and Business Overview
6.3.3 Biotage Automatic Peptide Continuous Synthesizer Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Biotage Automatic Peptide Continuous Synthesizer Product Portfolio
6.3.5 Biotage Recent Developments/Updates
6.4 CEM
6.4.1 CEM Corporation Information
6.4.2 CEM Description and Business Overview
6.4.3 CEM Automatic Peptide Continuous Synthesizer Sales, Revenue and Gross Margin (2018-2023)
6.4.4 CEM Automatic Peptide Continuous Synthesizer Product Portfolio
6.4.5 CEM Recent Developments/Updates
6.5 CSBio
6.5.1 CSBio Corporation Information
6.5.2 CSBio Description and Business Overview
6.5.3 CSBio Automatic Peptide Continuous Synthesizer Sales, Revenue and Gross Margin (2018-2023)
6.5.4 CSBio Automatic Peptide Continuous Synthesizer Product Portfolio
6.5.5 CSBio Recent Developments/Updates
6.6 AAPPTec
6.6.1 AAPPTec Corporation Information
6.6.2 AAPPTec Description and Business Overview
6.6.3 AAPPTec Automatic Peptide Continuous Synthesizer Sales, Revenue and Gross Margin (2018-2023)
6.6.4 AAPPTec Automatic Peptide Continuous Synthesizer Product Portfolio
6.6.5 AAPPTec Recent Developments/Updates
6.7 Activotec
6.6.1 Activotec Corporation Information
6.6.2 Activotec Description and Business Overview
6.6.3 Activotec Automatic Peptide Continuous Synthesizer Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Activotec Automatic Peptide Continuous Synthesizer Product Portfolio
6.7.5 Activotec Recent Developments/Updates
6.8 MultiSynTech
6.8.1 MultiSynTech Corporation Information
6.8.2 MultiSynTech Description and Business Overview
6.8.3 MultiSynTech Automatic Peptide Continuous Synthesizer Sales, Revenue and Gross Margin (2018-2023)
6.8.4 MultiSynTech Automatic Peptide Continuous Synthesizer Product Portfolio
6.8.5 MultiSynTech Recent Developments/Updates
6.9 NJ Biopharmaceuticals LLC
6.9.1 NJ Biopharmaceuticals LLC Corporation Information
6.9.2 NJ Biopharmaceuticals LLC Description and Business Overview
6.9.3 NJ Biopharmaceuticals LLC Automatic Peptide Continuous Synthesizer Sales, Revenue and Gross Margin (2018-2023)
6.9.4 NJ Biopharmaceuticals LLC Automatic Peptide Continuous Synthesizer Product Portfolio
6.9.5 NJ Biopharmaceuticals LLC Recent Developments/Updates
6.10 Peptide Machines, Inc.
6.10.1 Peptide Machines, Inc. Corporation Information
6.10.2 Peptide Machines, Inc. Description and Business Overview
6.10.3 Peptide Machines, Inc. Automatic Peptide Continuous Synthesizer Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Peptide Machines, Inc. Automatic Peptide Continuous Synthesizer Product Portfolio
6.10.5 Peptide Machines, Inc. Recent Developments/Updates
6.11 Protein Technologies, Inc.
6.11.1 Protein Technologies, Inc. Corporation Information
6.11.2 Protein Technologies, Inc. Automatic Peptide Continuous Synthesizer Description and Business Overview
6.11.3 Protein Technologies, Inc. Automatic Peptide Continuous Synthesizer Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Protein Technologies, Inc. Automatic Peptide Continuous Synthesizer Product Portfolio
6.11.5 Protein Technologies, Inc. Recent Developments/Updates
6.12 Intavis AG
6.12.1 Intavis AG Corporation Information
6.12.2 Intavis AG Automatic Peptide Continuous Synthesizer Description and Business Overview
6.12.3 Intavis AG Automatic Peptide Continuous Synthesizer Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Intavis AG Automatic Peptide Continuous Synthesizer Product Portfolio
6.12.5 Intavis AG Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Automatic Peptide Continuous Synthesizer Industry Chain Analysis
7.2 Automatic Peptide Continuous Synthesizer Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Automatic Peptide Continuous Synthesizer Production Mode & Process
7.4 Automatic Peptide Continuous Synthesizer Sales and Marketing
7.4.1 Automatic Peptide Continuous Synthesizer Sales Channels
7.4.2 Automatic Peptide Continuous Synthesizer Distributors
7.5 Automatic Peptide Continuous Synthesizer Customers
8 Automatic Peptide Continuous Synthesizer Market Dynamics
8.1 Automatic Peptide Continuous Synthesizer Industry Trends
8.2 Automatic Peptide Continuous Synthesizer Market Drivers
8.3 Automatic Peptide Continuous Synthesizer Market Challenges
8.4 Automatic Peptide Continuous Synthesizer Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
